drug
delpacibart zotadirsen
Phase 2updated 6mo agoby Avidity Biosciences Inc
Phase 2community read0 votes
indications
indications
Duchenne Muscular Dystrophy
all catalysts(0)
nothing on the calendar yet
Trials studying delpacibart zotadirsen
News(2)
- Novartis CEO keeps faith in Avidity deal despite taking $1.9B hit from del-desiran failNovartis CEO Vas Narasimhan has insisted that the phase 3 fail for del-desiran is just a “bump” in the Swiss pharma’s wider plans for the drug, despite costing the company an estimated $1.9 billion.fiercebiotech · 21d ago
- Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 testThe phase 3 Harbor trial of Novartis’ del-desiran has missed its primary endpoint, dealing a major blow to an asset that the Swiss drugmaker acquired in the $12 billion takeover of Avidity Bioscien…fiercebiotech · 2mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that